Related Experiment Video
Updated: Aug 4, 2026

Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli
Published on: March 20, 2016
Alginate- and Chitosan-Modified Gelatin Hydrogel Microbeads for Delivery of E. coli Phages
Farzaneh Moghtader1,2,3, Sencer Solakoglu2, Erhan Piskin1,3
1NanoBMT: Nanobiyomedtek Biyomedikal ve Biyoteknoloji San.Tic., Ltd. Sti., 48800 Köycegiz, Mugla, Turkey.
Abstract:
Bacterial infections are among the most significant health problems/concerns worldwide. A very critical concern is the rapidly increasing number of antibiotic-resistant bacteria, which requires much more effective countermeasures. As nature's antibacterial entities, bacteriophages shortly ("phages") are very important alternatives to antibiotics, having many superior features compared with antibiotics. The development of phage-carrying controlled-release formulations is still challenging due to the need to protect their activities in preparation, storage, and use, as well as the need to create more user-friendly forms by considering their application area/site/conditions. Here, we prepared gelatin hydrogel microbeads by a two-step process. Sodium alginate was included for modification within the initial recipes, and these composite microbeads were further coated with chitosan. Their swelling ratio, average diameters, and Zeta potentials were determined, and degradations in HCl were demonstrated. The target bacteria Escherichia coli (E.coli) and its specific phage (T4) were obtained from bacterial culture collections and propagated. Phages were loaded within the microbeads with a simple method. The phage release characteristics were investigated comparatively and were demonstrated here. High release rates were observed from the gelatin microbeads. It was possible to reduce the phage release rate using sodium alginate in the recipe and chitosan coating. Using these gelatin-based microbeads as phage carrier matrices-especially in lyophilized forms-significantly improved the phage stability even at room temperature. It was concluded that phage release from gelatin hydrogel microbeads could be further controlled by alginate and chitosan modifications and that user-friendly lyophilized phage formulations with a much longer shelf life could be produced.
Insights
Bacteriophages (phages) offer a promising alternative to antibiotics for combating resistant bacteria. This study developed novel gelatin microbeads to improve phage stability and control their release, creating user-friendly, long-lasting formulations.
Area of Science:
- Biomaterials Science
- Microbiology
- Drug Delivery
Background:
- Antibiotic resistance is a global health crisis, necessitating alternative treatments.
- Bacteriophages (phages) are natural antibacterial agents with potential against resistant bacteria.
- Developing stable and controlled-release phage formulations remains a significant challenge.
Purpose of the Study:
- To develop gelatin hydrogel microbeads for bacteriophage encapsulation.
- To investigate the effect of sodium alginate and chitosan on phage release and stability.
- To create user-friendly, lyophilized phage formulations with extended shelf life.
Main Methods:
- Two-step preparation of gelatin hydrogel microbeads, incorporating sodium alginate and chitosan coating.
- Characterization of microbead properties: swelling ratio, diameter, Zeta potential, and acid degradation.
- Encapsulation of T4 bacteriophage specific to Escherichia coli (E. coli) and evaluation of release kinetics.
Main Results:
- Gelatin microbeads showed high initial phage release rates.
- Incorporation of sodium alginate and chitosan significantly reduced phage release rates.
- Gelatin-based microbead formulations, especially lyophilized ones, enhanced phage stability at room temperature.
Conclusions:
- Gelatin hydrogel microbeads modified with alginate and chitosan offer controlled phage release.
- These modified microbeads can lead to user-friendly, lyophilized phage formulations with improved stability and shelf life.
- This approach presents a viable strategy for developing effective phage-based therapies against bacterial infections.
Related Concept Videos
Special Staining Techniques
Microbes in the Production of Fermented Foods
iChip
Microbiota of the Stomach and Small Intestine
Bacterial Gastroenteritis

